Kiran Mazumdar-Shaw Conferred with Lifetime Achievement Award by Indian Council of Medical Research
-
Mon, 18-Nov-2019
- Posted by: Biocon Biologics
No Comments
Biocon Features in the Prestigious ASIA IP ELITE List for the Fourth Consecutive Year
-
Tue, 12-Nov-2019
- Posted by: Biocon Biologics
Biocon’s Biologics Drug Products Facility in Bengaluru Receives EIR from U.S. FDA
-
Tue, 05-Nov-2019
- Posted by: Biocon Biologics
Biocon Moves Up to Rank No. 6 on Science Careers’ Top 20 Global Pharma & Biotech Employers List 2019
-
Mon, 28-Oct-2019
- Posted by: Biocon Biologics
Biocon Q2FY20 Earnings Revenue at Rs 1,611 Cr, Up 17 %; EBITDA at Rs 441 Cr, Up 12%; Net Profit (excluding exceptional item) at Rs 189 Cr, Up 3%
-
Wed, 23-Oct-2019
- Posted by: Biocon Biologics
Biocon Biologics & Just – Evotec Biologics Sign Licensing Deal for a Biosimilar Asset
-
Thu, 10-Oct-2019
- Posted by: Biocon Biologics
Biocon and Mylan Launch First Insulin Glargine Biosimilar, Semglee®, in Australia
-
Thu, 03-Oct-2019
- Posted by: Biocon Biologics
Kiran Mazumdar-Shaw Promises to Enable Universal Access to rh-Insulin by Reducing Prices to Less than 10 US cents /Day for LMICs
-
Thu, 26-Sep-2019
- Posted by: Biocon Biologics
Biocon Biologics Expands its R&D Footprint Through Acquisition
-
Tue, 24-Sep-2019
- Posted by: Biocon Biologics
U.S. FDA Completes Pre-Approval Inspection of Two New Biocon Biologics Facilities in Bengaluru
-
Fri, 20-Sep-2019
- Posted by: Biocon Biologics
